ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,569 | -29.8% | 1,972,484 | -1.3% | 0.03% | -26.3% |
| Q2 2023 | $56,402 | +63.1% | 1,999,354 | -0.5% | 0.04% | +52.0% |
| Q1 2023 | $34,580 | -22.3% | 2,010,409 | -9.0% | 0.02% | -26.5% |
| Q4 2022 | $44,519 | -99.9% | 2,210,442 | +0.1% | 0.03% | -10.5% |
| Q3 2022 | $47,840,000 | – | 2,208,669 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |